Baidu
map
WORLD J HEPATOL 润色咨询

World Journal of Hepatology

出版年份：暂无数据 年文章数：1680 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2114699, encodeId=98ae2114699e0, content=这个版面费是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30075311628, createdName=1488b46em13暂无昵称, createdTime=Wed Feb 15 10:38:12 CST 2023, time=2023-02-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1122763, encodeId=de091122e639b, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:57 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1122764, encodeId=52761122e6498, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:57 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071920, encodeId=786510e19203b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：HBL;肝病;乙肝<br>经验分享：有人看过这个嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:19:04 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2023-02-15 1488b46em13暂无昵称 来自黑龙江省

    这个版面费是多少

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2114699, encodeId=98ae2114699e0, content=这个版面费是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30075311628, createdName=1488b46em13暂无昵称, createdTime=Wed Feb 15 10:38:12 CST 2023, time=2023-02-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1122763, encodeId=de091122e639b, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:57 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1122764, encodeId=52761122e6498, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:57 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071920, encodeId=786510e19203b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：HBL;肝病;乙肝<br>经验分享：有人看过这个嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:19:04 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2021-12-28 衣谷

    引言和讨论如何写的不重复？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2114699, encodeId=98ae2114699e0, content=这个版面费是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30075311628, createdName=1488b46em13暂无昵称, createdTime=Wed Feb 15 10:38:12 CST 2023, time=2023-02-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1122763, encodeId=de091122e639b, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:57 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1122764, encodeId=52761122e6498, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:57 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071920, encodeId=786510e19203b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：HBL;肝病;乙肝<br>经验分享：有人看过这个嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:19:04 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2021-12-27 Mia

    和讨论比，引言撰写的方式有什么不同？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2114699, encodeId=98ae2114699e0, content=这个版面费是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30075311628, createdName=1488b46em13暂无昵称, createdTime=Wed Feb 15 10:38:12 CST 2023, time=2023-02-15, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=1122763, encodeId=de091122e639b, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:57 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1122764, encodeId=52761122e6498, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:57 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071920, encodeId=786510e19203b, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：HBL;肝病;乙肝<br>经验分享：有人看过这个嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220325/2989db34e5f64505b58783b568b8e1b6/a8e736ad82ba412a9c338ac6d789c05a.png, createdBy=956d5621919, createdName=ms6000000292023383, createdTime=Fri Nov 19 23:19:04 CST 2021, time=2021-11-19, status=1, ipAttribution=)]
    2021-11-19 ms6000000292023383

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：HBL;肝病;乙肝
    经验分享：有人看过这个嘛

    0

共6条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map